Hyperglycaemic preterm babies have sex differences in insulin secretion (2015)
Type of ContentJournal Article
PublisherUniversity of Canterbury. Mechanical Engineering
Background: Hyperglycaemia is a common complication of prematurity and is associated with neonatal mortality and morbidity, yet the aetiology is incompletely understood. C-peptide has been used in adults to estimate endogenous insulin secretion due to its simple clearance kinetics. Objective: To determine insulin secretion calculated from plasma C-peptide concentrations in hyperglycaemic preterm babies. Methods: A retrospective analysis of a cohort of 41 very preterm babies (median gestational age, weeks: 27.2 (26.2-28.7)) enrolled in a randomised controlled trial of tight glycaemic control when they developed hyperglycaemia (2 consecutive blood glucose concentrations (BGC) > 8.5 mmol.L-1). Insulin secretion was determined using a steady state analysis of a 2 compartment C-peptide kinetic model. Results: BGC, plasma insulin concentration, plasma C-peptide concentrations and insulin secretion were higher at randomisation than 1-2 weeks following randomisation (p≤0.02). Insulin secretion was higher in girls (11.7 (5.3-18.7) vs. 4.7 (2.1-8.3) mU.L-1.kg-1.min-1, p<0.005) with no difference in clinical characteristics, BGC, plasma insulin concentration, or nutrition between the sexes (p>0.25). Insulin secretion was lower in samples taken during exogenous insulin delivery (3.7 (1.8 - 6.9) vs. 9.8 (4.7 - 17.8) mU.L-1.kg-1.min-1, p=0.02). Conclusions: Insulin secretion was higher when babies had higher BGC, indicating endogenous insulin secretion is sensitive to BGC. Girls had higher insulin secretion, at similar blood glucose and plasma insulin concentrations, than boys.
CitationDickson, J.L., Chase, J.G., Pretty, C.G., Gunn, C.A., Alsweiler, J.A. (2015) Hyperglycaemic preterm babies have sex differences in insulin secretion. Neonatology, 108(2), pp. 93-98.
This citation is automatically generated and may be unreliable. Use as a guide only.
Keywordspreterm; hyperglycaemia; insulin secretion; sexual dimorphism
ANZSRC Fields of Research40 - Engineering::4003 - Biomedical engineering::400303 - Biomechanical engineering
10 - Technology::1004 - Medical Biotechnology
Showing items related by title, author, creator and subject.
A C-Peptide-Based Model of Pancreatic Insulin Secretion in Extremely Preterm Neonates in Intensive Care Dickson, J.L.; Alsweiler, J.; Gunn, C.A.; Pretty, C.G.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2016)Background: Model-based glycaemic control relies on sufficiency of underlying models to describe underlying patient physiology. In particular, very preterm infant glucose-insulin metabolism can differ significantly from ...
Endogenous insulin secretion and suppression during and after sepsis in critically ill patients – implications for TGC protocols Pretty, C.G.; Docherty, P.D.; Pfeiffer, L.; Jamaludin, U.; Shaw, Geoff; Le Compte, A.J.; Chase, Geoff (University of Canterbury. Mechanical Engineering, 2011)Introduction: Insulin infusions over 2 U/hr can suppress endogenous insulin secretion in healthy subjects 30-45% . Virtually all tight glycaemic control (TGC) protocols deliver insulin via infusion. This study examines ...
Impact of glucocorticoids on insulin resistance in the critically ill Pretty, C.G.; Chase, Geoff; Lin, J.; Shaw, Geoff; Le Compte, A.J.; Razak, N.; Parente, J.D. (University of Canterbury. Mathematics and StatisticsUniversity of Canterbury. Mechanical Engineering, 2011)Glucocorticoids (GCs) have been shown to reduce insulin sensitivity in healthy individuals. Widely used in critical care to treat a variety of inflammatory and allergic disorders, they may inadvertently exacerbate ...